Healthcare & Life Sciences
Travere Therapeutics
United Statestravere.com/
Travere Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
activeseries-c-plus
series-c-plus
Stage
2018
Founded
2
Investors
About Travere Therapeutics
Based in the United States, Travere Therapeutics is a startup founded in 2018. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Travere Therapeutics is a biopharmaceutical company that develops and commercializes therapies for rare kidney diseases including Focal Segmental Glomerulosclerosis (FSGS), IgA Nephropathy (IgAN), Classical Homocystinuria (HCU), and Cystinuria.
Explore Travere Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.